Cabaletta Bio Inc
NASDAQ:CABA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cabaletta Bio Inc
NASDAQ:CABA
|
US |
|
A
|
Alpine Immune Sciences Inc
F:34LA
|
US |
|
A
|
ACME Holdings Bhd
KLSE:ACME
|
MY |
|
P
|
People's United Financial Inc
LSE:0KH6
|
US |
|
MCC Meili Cloud Computing Industry Investment Co Ltd
SZSE:000815
|
CN |
|
N
|
Nippon Parking Development Co Ltd
TSE:2353
|
JP |
|
Rts Power Corporation Ltd
BSE:531215
|
IN |
|
Lizhi Inc
NASDAQ:SOGP
|
CN |
|
M
|
Magyar Telekom Tavkozlesi Nyrt
BET:MTELEKOM
|
HU |
|
International Business Machines Corp
NYSE:IBM
|
US |
Cash Flow Statement
Cash Flow Statement
Cabaletta Bio Inc
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||||
| Net Income |
(16)
|
(18)
|
(13)
|
(17)
|
(21)
|
(26)
|
(29)
|
(33)
|
(36)
|
(39)
|
(42)
|
(46)
|
(50)
|
(51)
|
(51)
|
(53)
|
(56)
|
(57)
|
(62)
|
(68)
|
(77)
|
(90)
|
(104)
|
(116)
|
(127)
|
(144)
|
(159)
|
(168)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
5
|
5
|
5
|
5
|
2
|
|
| Stock-Based Compensation |
1
|
2
|
2
|
2
|
3
|
3
|
4
|
4
|
5
|
5
|
6
|
6
|
6
|
7
|
7
|
7
|
8
|
9
|
10
|
11
|
13
|
15
|
17
|
19
|
21
|
22
|
22
|
21
|
|
| Other Non-Cash Items |
9
|
9
|
2
|
2
|
3
|
3
|
4
|
5
|
5
|
5
|
6
|
6
|
6
|
7
|
7
|
10
|
11
|
12
|
14
|
13
|
14
|
18
|
22
|
21
|
24
|
28
|
31
|
36
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
|
| Change in Working Capital |
0
|
0
|
2
|
(2)
|
(1)
|
(0)
|
(0)
|
2
|
(0)
|
3
|
3
|
6
|
4
|
1
|
(1)
|
(4)
|
(3)
|
(3)
|
(2)
|
0
|
(4)
|
(3)
|
(1)
|
2
|
3
|
7
|
4
|
(0)
|
|
| Cash from Operating Activities |
(7)
N/A
|
(9)
-31%
|
(10)
-11%
|
(16)
-59%
|
(19)
-17%
|
(23)
-20%
|
(25)
-13%
|
(27)
-5%
|
(31)
-14%
|
(29)
+3%
|
(33)
-11%
|
(34)
-4%
|
(38)
-12%
|
(43)
-13%
|
(45)
-4%
|
(46)
-4%
|
(46)
+0%
|
(47)
-1%
|
(49)
-6%
|
(54)
-9%
|
(65)
-21%
|
(74)
-14%
|
(82)
-10%
|
(88)
-8%
|
(95)
-8%
|
(105)
-10%
|
(119)
-14%
|
(131)
-10%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(11)
|
(9)
|
(7)
|
(5)
|
8
|
8
|
7
|
(45)
|
(46)
|
(24)
|
(25)
|
50
|
2
|
(23)
|
(22)
|
(47)
|
26
|
38
|
50
|
0
|
(24)
|
(87)
|
(49)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-111%
|
(0)
-11%
|
(1)
-64%
|
(1)
-7%
|
(12)
-1 474%
|
(10)
+13%
|
(8)
+21%
|
(5)
+32%
|
7
N/A
|
7
+4%
|
6
-15%
|
(46)
N/A
|
(48)
-4%
|
(26)
+46%
|
(27)
-4%
|
47
N/A
|
0
-100%
|
(24)
N/A
|
(22)
+6%
|
(48)
-113%
|
24
N/A
|
36
+51%
|
47
+30%
|
47
+0%
|
(26)
N/A
|
(88)
-243%
|
(50)
+43%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
87
|
74
|
74
|
120
|
70
|
71
|
71
|
(0)
|
2
|
10
|
35
|
49
|
47
|
39
|
14
|
33
|
33
|
127
|
127
|
188
|
188
|
100
|
100
|
13
|
11
|
102
|
102
|
107
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(4)
|
(5)
|
(6)
|
|
| Other |
(0)
|
0
|
(2)
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
87
N/A
|
74
-15%
|
72
-3%
|
120
+67%
|
70
-41%
|
71
+1%
|
73
+3%
|
(0)
N/A
|
2
N/A
|
10
+362%
|
35
+249%
|
49
+38%
|
47
-4%
|
39
-17%
|
14
-65%
|
33
+141%
|
33
+1%
|
127
+284%
|
127
+0%
|
188
+47%
|
194
+4%
|
100
-48%
|
100
0%
|
12
-88%
|
4
-63%
|
97
+2 178%
|
96
-1%
|
100
+4%
|
|
| Change in Cash | |||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Net Change in Cash |
80
N/A
|
64
-20%
|
61
-5%
|
103
+68%
|
51
-51%
|
37
-27%
|
38
+2%
|
(35)
N/A
|
(34)
+3%
|
(13)
+63%
|
10
N/A
|
21
+117%
|
(38)
N/A
|
(52)
-39%
|
(57)
-9%
|
(41)
+29%
|
34
N/A
|
81
+136%
|
54
-33%
|
112
+105%
|
81
-27%
|
51
-38%
|
55
+9%
|
(29)
N/A
|
(43)
-48%
|
(33)
+24%
|
(110)
-235%
|
(81)
+27%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||||
| Free Cash Flow |
(7)
N/A
|
(9)
-33%
|
(10)
-11%
|
(17)
-60%
|
(19)
-16%
|
(23)
-19%
|
(26)
-13%
|
(27)
-5%
|
(31)
-13%
|
(30)
+2%
|
(34)
-12%
|
(35)
-4%
|
(39)
-12%
|
(45)
-14%
|
(47)
-5%
|
(49)
-4%
|
(49)
0%
|
(48)
+1%
|
(50)
-3%
|
(54)
-8%
|
(66)
-22%
|
(76)
-15%
|
(84)
-10%
|
(90)
-8%
|
(97)
-8%
|
(106)
-9%
|
(120)
-13%
|
(132)
-10%
|
|